Heparin-induced thrombocytopenia (HIT) is a serious immune-mediated adverse reaction to heparin therapy characterized by a decrease in platelet count and an increased risk of thrombosis. Prompt recognition and management are crucial to prevent complications, involving cessation of heparin and initiation of alternative anticoagulation therapy.